Health ❯Healthcare ❯Research ❯Clinical Trials

Drug Efficacy

First Patients in Germany Receive Lecanemab for Early Alzheimer’s

A cautious rollout reflects strict MRI-based screening alongside modest, early-stage benefits.

NICE Poised to Reject NHS Coverage for Breakthrough Alzheimer’s Drugs